Tag Archives: Zaltrap

Why Sanofi’s Zaltrap Deal Won’t Help Patients

I got excited when I read the New York Times story Nov. 9 (“Sanofi Halves Price of Cancer Drug Zaltrap After Sloan-Kettering Rejection)”. Zaltrap is an intravenous infusion drug for metastatic colorectal cancer. It is used for advanced cancer that … Continue reading

Posted in Drug costs | Tagged , , , , , | 1 Comment